ArticleOncoimmunology2012

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.

Manuarii Manuel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.